Inotuzumab ozogamicin is a CD 22 - directed antibody-drug conjugate which is prescribed to treat adult patients suffering from relapsed or refractory B-cell precursor acute lymphoblastic leukemia, a type of blood cancer.
Molgramostim is an immune stimulator which is prescribed to correct neutropenia -the condition that causes low levels of neutrophils - following a high dose chemotherapy regimen or bone marrow transplantation.
Tegafur, gimeracil, and oteracil combination drugs are used along with cisplatin to treat advanced stomach cancer or unresectable cancer (gastric cancer that cannot be removed completely by surgery) in adult patients.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer